End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
829.8 INR | -1.18% |
|
-2.77% | +26.28% |
05-15 | Granules India posts Q4 revenue fall on weak paracetamol sales, price erosion | RE |
04-25 | Transcript : Glenmark Life Sciences Limited, Q4 2024 Earnings Call, Apr 25, 2024 |
Chart calendar Glenmark Life Sciences Limited
Upcoming events on Glenmark Life Sciences Limited
Past events on Glenmark Life Sciences Limited
18/06/2024 | Investor Meeting - Julius Baer |
16/06/2024 | Investor Meeting - Quest Investment Advisors |
04/06/2024 | Mirae Asset Capital Markets India Conference |
29/05/2024 | B&K Securities Trinity Investor Conference |
21/05/2024 | Investor Meeting - Polar Capital |
16/05/2024 | Investor Meeting - Grandeur Peak Global Advisors |
25/04/2024 11:30 | Q4 2024 Earnings Call |
25/04/2024 10:20 | Q4 2024 Earnings Release |
14/03/2024 | Non Deal Roadshow - Day 4 |
13/03/2024 | Non Deal Roadshow - Day 3 |
12/03/2024 | Non Deal Roadshow - Day 2 |
11/03/2024 | Non Deal Roadshow - Day 1 |
24/01/2024 03:00 | Q3 2024 Earnings Call |
23/01/2024 11:50 | Q3 2024 Earnings Release |
20/10/2023 11:30 | Q2 2024 Earnings Call |
20/10/2023 08:41 | Q2 2024 Earnings Release |
26/09/2023 10:30 | Annual General Meeting |
21/07/2023 11:30 | Q1 2024 Earnings Call |
21/07/2023 08:25 | Q1 2024 Earnings Release |
28/04/2023 04:00 | Q4 2023 Earnings Call |
Past dividends on Glenmark Life Sciences Limited
16/10/2023 | Interim Payment 22.5 INR |
23/03/2023 | Interim Payment 21 INR |
14/09/2022 | Final Payment 10.5 INR |
21/11/2021 | Interim Payment 10.5 INR |
Annual results
Fiscal Period | March | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
Net sales Million INR | Released Forecast Spread | 18 852 | 21 379 21 326 0.25% | 21 612 20 860 3.61% | 22 832 23 913 -4.52% |
EBITDA Million INR | Released Forecast Spread | 0,00 | 6 308 6 205 1.66% | 6 423 5 875 9.33% | 6 742 7 353 -8.31% |
EBIT Million INR | Released Forecast Spread | 0,00 | 5 929 5 790 2.4% | 6 002 5 514 8.85% | 6 208 6 999 -11.3% |
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 0,00 | 5 649 5 611 0.68% | 6 286 5 749 9.35% | 6 313 7 057 -10.54% |
Net income Million INR | Released Forecast Spread | 0,00 | 4 187 4 132 1.33% | 4 670 4 264 9.51% | 4 709 5 213 -9.66% |
EPS INR | Released Forecast Spread | 0,00 | 35,6 33,7 5.71% | 38,1 34,8 9.61% | 38,4 42,5 -9.63% |
Announcement Date | 20/07/21 | 20/04/22 | 27/04/23 | 25/04/24 |
Quarterly results
Fiscal Period | Marzo | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million INR | Released Forecast Spread | 5 639 5 568 1.26% | 5 260 5 363 -1.91% | 5 192 5 002 3.8% | 4 994 5 386 -7.29% | 5 093 5 275 -3.45% | 5 407 5 268 2.64% | 6 213 5 486 13.26% | 5 785 5 842 -0.98% | 5 980 | 6 025 | 6 071 |
EBITDA Million INR | Released Forecast Spread | 1 496 1 590 -5.91% | 1 468 1 389 5.66% | 1 436 1 446 -0.66% | 1 455 1 467 -0.85% | 2 064 1 536 34.39% | 1 932 1 705 13.29% | 2 012 | 1 693 | 1 702 | ||
EBIT Million INR | Released Forecast Spread | 1 598 1 542 3.58% | 1 399 1 452 -3.65% | 1 378 1 330 3.54% | 1 464 1 496 -2.18% | 1 437 1 588 -9.49% | 1 413 1 528 -7.55% | 1 949 1 503 29.66% | 1 824 1 643 11% | 1 947 | 1 708 | |
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 1 820 1 580 15.19% | 1 729 | |||||||||
Net income Million INR | Released Forecast Spread | 1 037 1 121 -7.48% | 1 087 996 9.17% | 1 069 1 039 2.87% | 1 050 1 087 -3.41% | 1 464 1 087 34.64% | 1 355 1 201 12.83% | 1 419 | 1 182 | 1 176 | ||
EPS INR | Released Forecast Spread | 11,1 9,60 15.1% | 10,4 | |||||||||
Announcement Date | 10/11/21 | 08/02/22 | 20/04/22 | 04/08/22 | 21/10/22 | 27/01/23 | 27/04/23 | 21/07/23 | - | - | - |
Past sector events for Glenmark Life Sciences Limited
21/06/2024 16:28 | DEVA HOLDING: Q1 2024 Earnings Release |
13/06/2024 22:21 | EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q1 2024 Earnings Release |
11/06/2024 06:30 | BORA PHARMACEUTICALS CO., LTD.: June 2024 Sales and Revenue Release |
07/06/2024 11:33 | SCINOPHARM TAIWAN, LTD.: May 2024 Sales and Revenue Release |
07/06/2024 10:17 | LOTUS PHARMACEUTICAL CO., LTD.: May 2024 Sales and Revenue Release |
30/05/2024 13:08 | SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
30/05/2024 12:00 | ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release |
30/05/2024 07:24 | MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release |
29/05/2024 13:00 | FDC LIMITED: Q4 2024 Earnings Release |
29/05/2024 10:26 | JUBILANT PHARMOVA LIMITED: Q4 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- GLS Stock
- Calendar Glenmark Life Sciences Limited